149 related articles for article (PubMed ID: 33766378)
1. Chitosan-glucuronic acid conjugate coated mesoporous silica nanoparticles: A smart pH-responsive and receptor-targeted system for colorectal cancer therapy.
Narayan R; Gadag S; Cheruku SP; Raichur AM; Day CM; Garg S; Manandhar S; Pai KSR; Suresh A; Mehta CH; Nayak Y; Kumar N; Nayak UY
Carbohydr Polym; 2021 Jun; 261():117893. PubMed ID: 33766378
[TBL] [Abstract][Full Text] [Related]
2. Aptamer-modified chitosan-capped mesoporous silica nanoparticles for co-delivery of cytarabine and daunorubicin in leukemia.
Heydari SR; Ghahremani MH; Atyabi F; Bafkary R; Jaafari MR; Dinarvand R
Int J Pharm; 2023 Nov; 646():123495. PubMed ID: 37806507
[TBL] [Abstract][Full Text] [Related]
3. Sterically Stabilised Polymeric Mesoporous Silica Nanoparticles Improve Doxorubicin Efficiency: Tailored Cancer Therapy.
Moodley T; Singh M
Molecules; 2020 Feb; 25(3):. PubMed ID: 32046364
[TBL] [Abstract][Full Text] [Related]
4. Loading cinnamon oil into pH-sensitive chitosan grafted mesoporous silica nanoparticles via supercritical carbon dioxide.
Lei H; Jiang Y; Liu J; Guan Y; Song S; Tang C; Fei S; Zhang H
Pak J Pharm Sci; 2024 Jan; 37(1(Special)):235-243. PubMed ID: 38747275
[TBL] [Abstract][Full Text] [Related]
5. A pH-sensitive silica nanoparticles for colon-specific delivery and controlled release of catechin: Optimization of loading efficiency and in vitro release kinetics.
Kassem AM; Almukainzi M; Faris TM; Ibrahim AH; Anwar W; Elbahwy IA; El-Gamal FR; Zidan MF; Akl MA; Abd-ElGawad AM; Elshamy AI; Elmowafy M
Eur J Pharm Sci; 2024 Jan; 192():106652. PubMed ID: 38008226
[TBL] [Abstract][Full Text] [Related]
6. Natural material-decorated mesoporous silica nanoparticle container for multifunctional membrane-controlled targeted drug delivery.
Hu Y; Ke L; Chen H; Zhuo M; Yang X; Zhao D; Zeng S; Xiao X
Int J Nanomedicine; 2017; 12():8411-8426. PubMed ID: 29200852
[TBL] [Abstract][Full Text] [Related]
7. Targeted anticancer potential against glioma cells of thymoquinone delivered by mesoporous silica core-shell nanoformulations with pH-dependent release.
Shahein SA; Aboul-Enein AM; Higazy IM; Abou-Elella F; Lojkowski W; Ahmed ER; Mousa SA; AbouAitah K
Int J Nanomedicine; 2019; 14():5503-5526. PubMed ID: 31410001
[TBL] [Abstract][Full Text] [Related]
8. Mesoporous Silica Nanoparticle-Coated Microneedle Arrays for Intradermal Antigen Delivery.
Tu J; Du G; Reza Nejadnik M; Mönkäre J; van der Maaden K; Bomans PHH; Sommerdijk NAJM; Slütter B; Jiskoot W; Bouwstra JA; Kros A
Pharm Res; 2017 Aug; 34(8):1693-1706. PubMed ID: 28536970
[TBL] [Abstract][Full Text] [Related]
9. CAPN2-responsive mesoporous silica nanoparticles: A promising nanocarrier for targeted therapy of pancreatic cancer.
Slapak EJ; El Mandili M; Ten Brink MS; Kros A; Bijlsma MF; Spek CA
Cancer Lett; 2024 May; 590():216845. PubMed ID: 38589004
[TBL] [Abstract][Full Text] [Related]
10. Mesoporous Silicon Nanoparticles with Liver-Targeting and pH-Response-Release Function Are Used for Targeted Drug Delivery in Liver Cancer Treatment.
Wei J; Tan Y; Bai Y; He J; Cao H; Guo J; Su Z
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473773
[TBL] [Abstract][Full Text] [Related]
11. Engineered pH-Responsive Mesoporous Carbon Nanoparticles for Drug Delivery.
Gisbert-Garzarán M; Berkmann JC; Giasafaki D; Lozano D; Spyrou K; Manzano M; Steriotis T; Duda GN; Schmidt-Bleek K; Charalambopoulou G; Vallet-Regí M
ACS Appl Mater Interfaces; 2020 Apr; 12(13):14946-14957. PubMed ID: 32141284
[TBL] [Abstract][Full Text] [Related]
12. Targeted Stimuli-Responsive Mesoporous Silica Nanoparticles for Bacterial Infection Treatment.
Colilla M; Vallet-Regí M
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33203098
[TBL] [Abstract][Full Text] [Related]
13. PEG-Coated Large Mesoporous Silicas as Smart Platform for Protein Delivery and Their Use in a Collagen-Based Formulation for 3D Printing.
Banche-Niclot F; Montalbano G; Fiorilli S; Vitale-Brovarone C
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572076
[TBL] [Abstract][Full Text] [Related]
14. A dual catalytic functionalized hollow mesoporous silica-based nanocarrier coated with bacteria-derived exopolysaccharides for targeted delivery of irinotecan to colorectal cancer cells.
Fatemi M; Meshkini A; Matin MM
Int J Biol Macromol; 2024 Feb; 259(Pt 1):129179. PubMed ID: 38181911
[TBL] [Abstract][Full Text] [Related]
15. pH stimulus-responsive hybrid nanoparticles: A system designed for follicular delivery of brazilian plant-derived 5-alpha-reductase enzyme inhibitors.
Morais RP; de Oliveira CC; Riegel-Vidotti IC; Marino CEB
Int J Pharm; 2024 Jan; 650():123689. PubMed ID: 38072149
[TBL] [Abstract][Full Text] [Related]
16. Environmental stimulus-responsive mesoporous silica nanoparticles as anticancer drug delivery platforms.
Zhao H; Li Y; Chen J; Zhang J; Yang Q; Cui J; Shi A; Wu J
Colloids Surf B Biointerfaces; 2024 Feb; 234():113758. PubMed ID: 38241892
[TBL] [Abstract][Full Text] [Related]
17. Carbohydrate polymers-based surface modified nano delivery systems for enhanced target delivery to colon cancer - A review.
Ibrahim IAA; Alzahrani AR; Alanazi IM; Shahzad N; Shahid I; Falemban AH; Azlina MFN; Arulselvan P
Int J Biol Macromol; 2023 Dec; 253(Pt 2):126581. PubMed ID: 37652322
[TBL] [Abstract][Full Text] [Related]
18. Targeted delivery of anti-miR-155 by functionalized mesoporous silica nanoparticles for colorectal cancer therapy.
Li Y; Duo Y; Bi J; Zeng X; Mei L; Bao S; He L; Shan A; Zhang Y; Yu X
Int J Nanomedicine; 2018; 13():1241-1256. PubMed ID: 29535520
[TBL] [Abstract][Full Text] [Related]
19. The practicality of mesoporous silica nanoparticles as drug delivery devices and progress toward this goal.
Roggers R; Kanvinde S; Boonsith S; Oupický D
AAPS PharmSciTech; 2014 Oct; 15(5):1163-71. PubMed ID: 24871552
[TBL] [Abstract][Full Text] [Related]
20. Controlled drug delivery systems for cancer based on mesoporous silica nanoparticles.
Iturrioz-Rodríguez N; Correa-Duarte MA; Fanarraga ML
Int J Nanomedicine; 2019; 14():3389-3401. PubMed ID: 31190798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
